CARD11 (Q9BXL7) variants and mutations
CARD11 (also known as Q9BXL7) is a human protein-coding gene encoding a caspase recruitment domain-containing protein 11 protein. It assembles the CARD11-BCL10-MALT1 signaling complex after antigen-receptor activation, allowing lymphocytes to activate NF-kappaB and related pathways. Gain-of-function variants cause lymphoproliferative disease, while loss-of-function or dominant-negative variants can cause immunodeficiency or severe atopy. This analysis covers 2,253 CARD11 variants and mutations. Of these, 78% have computational variant effect predictions. Disease context includes severe combined immunodeficiency due to CARD11 deficiency, BENTA disease, and immunodeficiency 11b with atopic dermatitis. Example CARD11 variants include M1I, P2T, and G3E.
Variant analysis overview
- Gene: CARD11
- Protein: Q9BXL7
- UniProt accession: Q9BXL7
- Organism: Homo sapiens
- Variants analyzed: 2253
- Variant scope: all variants
- Completed: 2026-08-18
Variant and mutation evidence
- Variant composition: 2,103 unspecified-consequence records; 84 synonymous variants; 55 missense variants; 6 frameshift variants; 3 in-frame deletions; 2 splice-region variants
- Prediction scores: 1,762 variants have prediction scores (78% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: severe combined immunodeficiency due to CARD11 deficiency, BENTA disease, immunodeficiency 11b with atopic dermatitis, asthma, diffuse large B-cell lymphoma, autoimmune lymphoproliferative syndrome, combined immunodeficiency, severe combined immunodeficiency, allergic rhinitis, colorectal adenocarcinoma, skin squamous cell carcinoma, cutaneous melanoma.
Protein structure and variant hotspots
- Protein features: 3 domains; 10 post-translational modification sites.
- Structural context: 691 variants have structural context.
- PTM context: 12 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, AlphaFold DB, gnomAD constraint, Open Targets, ClinGen, MaveDB, LitVar.
Notable CARD11 variants
Examples include M1I, P2T, G3E, G3R, G5R, P6R, P6T, E7Q. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1I (p.Met1Ile), rs746425765, ClinGen CA4132917, ClinVar RCV000812593, ClinGen CA366640284, MetaLR 0.16, MetaSVM -0.89, Uncertain significance, BENTA disease; Severe combined immunodeficiency due to CARD11 deficiency
- P2T (p.Pro2Thr), Ensembl rs2114975166, REVEL 0.16, CADD 22.60
- G3E (p.Gly3Glu), rs1208108119, ClinGen CA366648161, NCI-TCGA Cosmic COSV6272, ClinVar RCV002755336, REVEL 0.09, CADD 25.20, Uncertain significance, BENTA disease; Severe combined immunodeficiency due to CARD11 deficiency
- G3R (p.Gly3Arg), gnomAD rs1780842161, REVEL 0.11, CADD 34.00
- G5R (p.Gly5Arg), rs1258227375, TOPMed rs1258227375, gnomAD rs1258227375, ClinGen CA366648152, REVEL 0.06, CADD 22.40, Uncertain significance, BENTA disease; Severe combined immunodeficiency due to CARD11 deficiency
- P6R (p.Pro6Arg), Ensembl rs2115094356, MetaLR 0.14, MetaSVM -0.98
- P6T (p.Pro6Thr), rs191347765, ClinGen CA4132894, ClinVar RCV000969524, ClinVar RCV006443554, REVEL 0.08, CADD 20.80, Likely benign, BENTA disease; Severe combined immunodeficiency due to CARD11 deficiency; not pr
- E7Q (p.Glu7Gln), Ensembl rs2115094351, MetaLR 0.08, MetaSVM -1.02
- M8I (p.Met8Ile), Ensembl rs1780509966, MetaLR 0.12, MetaSVM -0.98
- M8R (p.Met8Arg), rs368132142, ESP rs368132142, gnomAD rs368132142, REVEL 0.18, CADD 23.80, Variant assessed as somatic; moderate impact.
- D10E (p.Asp10Glu), Ensembl rs2115094329, REVEL 0.07, CADD 21.10
- Y11* (p.Tyr11Ter), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- Y11C (p.Tyr11Cys), gnomAD rs1403650501, REVEL 0.04, CADD 19.40
- M12T (p.Met12Thr), rs2535142240, ClinGen CA366648097, ClinVar RCV003802304, REVEL 0.02, CADD 19.80, Uncertain significance, Severe combined immunodeficiency due to CARD11 deficiency; BENTA disease
- M12V (p.Met12Val), NCI-TCGA Cosmic COSV6271, MetaLR 0.05, MetaSVM -0.99, Variant assessed as somatic; moderate impact.
- E13D (p.Glu13Asp), Ensembl rs2115094323, MetaLR 0.14, MetaSVM -0.96
- E13K (p.Glu13Lys), NCI-TCGA Cosmic COSV6271, REVEL 0.11, CADD 23.20, Variant assessed as somatic; moderate impact.
- T14M (p.Thr14Met), rs1192456063, NCI-TCGA Cosmic COSV6271, TOPMed rs1192456063, gnomAD rs1192456063, REVEL 0.11, CADD 23.00, Uncertain significance, BENTA disease; Severe combined immunodeficiency due to CARD11 deficiency
- D17G (p.Asp17Gly), rs1053147582, ClinGen CA152755905, ClinVar RCV000813459, TOPMed rs1053147582, REVEL 0.18, CADD 24.40, Uncertain significance, BENTA disease; Severe combined immunodeficiency due to CARD11 deficiency
- D17N (p.Asp17Asn), Ensembl rs1780509475, MetaLR 0.05, MetaSVM -1.00
- E18A (p.Glu18Ala), rs2535142144, ClinGen CA366648053, ClinVar RCV003815594, Uncertain significance, Severe combined immunodeficiency due to CARD11 deficiency; BENTA disease
- E18K (p.Glu18Lys), NCI-TCGA Cosmic COSV6272, TOPMed rs1780509303, gnomAD rs1780509303, REVEL 0.14, CADD 24.20, Variant assessed as somatic; moderate impact.
- E19* (p.Glu19Ter), Ensembl rs2115094287
- E19K (p.Glu19Lys), Ensembl rs2115094287, REVEL 0.13, CADD 26.20
- E19Q (p.Glu19Gln), Ensembl rs2115094287, MetaLR 0.04, MetaSVM -1.07
- D20H (p.Asp20His), Ensembl rs1780509131
- D20N (p.Asp20Asn), Ensembl rs1780509131, REVEL 0.11, CADD 23.90
- D20Y (p.Asp20Tyr), Ensembl rs1780509131
- A21T (p.Ala21Thr), rs775081227, ClinGen CA152755890, NCI-TCGA Cosmic COSV1007, ClinVar RCV001039875, REVEL 0.11, CADD 23.50, Uncertain significance, Severe combined immunodeficiency due to CARD11 deficiency; BENTA disease
- L22F (p.Leu22Phe), Ensembl rs2115094265, Uncertain significance, BENTA disease; Severe combined immunodeficiency due to CARD11 deficiency
- L22M (p.Leu22Met), Ensembl rs2115094268
- W23L (p.Trp23Leu), Ensembl rs2115094263, MetaLR 0.18, MetaSVM -0.71
- E24D (p.Glu24Asp), Ensembl rs2115094258, MetaLR 0.13, MetaSVM -0.95, Likely benign
- V26E (p.Val26Glu), Ensembl rs2115094238
- V26L (p.Val26Leu), Ensembl rs2115094241
- V26M (p.Val26Met), Ensembl rs2115094241
- C28R (p.Cys28Arg), rs2535142031, ClinGen CA366647981, ClinVar RCV003012133, ClinVar RCV005308892, REVEL 0.33, CADD 22.30, Uncertain significance, BENTA disease; Severe combined immunodeficiency due to CARD11 deficiency; Inborn
- C28Y (p.Cys28Tyr), Ensembl rs2115094226, REVEL 0.31, CADD 24.00
- N29T (p.Asn29Thr), Ensembl rs1583410862, MetaLR 0.08, MetaSVM -1.12
- R30G (p.Arg30Gly), rs145474800, ClinGen CA366647966, ClinVar RCV001542760, ESP rs145474800, AlphaMissense 0.98, MetaLR 0.30, Likely pathogenic, BENTA disease
- R30Q (p.Arg30Gln), rs1554276653, ClinGen CA366647963, ClinVar RCV000540862, Ensembl rs1554276653, REVEL 0.64, CADD 28.20, Conflicting interpretations, Primary immunodeficiency or monogenic inflammatory bowel disease; BENTA disease
- R30W (p.Arg30Trp), rs145474800, ClinGen CA366647967, ClinVar RCV000528697, ClinVar RCV000788795, AlphaMissense 0.98, MetaLR 0.30, Pathogenic/Likely pathogenic, Immunodeficiency 11b with atopic dermatitis; Severe combined immunodeficiency du
- H31D (p.His31Asp), Ensembl rs1562496455, Uncertain significance
- H31Q (p.His31Gln), NCI-TCGA Cosmic COSV1007, Variant assessed as somatic; moderate impact.
- H31Y (p.His31Tyr), rs1562496455, ClinGen CA366647960, ClinVar RCV000762445, Ensembl rs1562496455, AlphaMissense 0.88, MetaLR 0.13, Uncertain significance, not provided
- M32I (p.Met32Ile), Ensembl rs2115094191, NCI-TCGA TCGA novel, MetaLR 0.03, MetaSVM -1.06, Variant assessed as somatic; moderate impact.
- M32T (p.Met32Thr), rs1236228710, ClinGen CA366647951, ClinVar RCV001340659, ClinVar RCV004601461, REVEL 0.05, CADD 19.40, Uncertain significance, Severe combined immunodeficiency due to CARD11 deficiency; BENTA disease; Inborn
- M32V (p.Met32Val), rs1359873709, ClinGen CA366647953, ClinVar RCV001947904, TOPMed rs1359873709, REVEL 0.11, CADD 20.40, Uncertain significance, Severe combined immunodeficiency due to CARD11 deficiency; BENTA disease
- L33F (p.Leu33Phe), Ensembl rs2115094187
- L33H (p.Leu33His), Ensembl rs2115094185
- S34N (p.Ser34Asn), NCI-TCGA Cosmic COSV1007, REVEL 0.10, CADD 23.10, Variant assessed as somatic; moderate impact.
- S34T (p.Ser34Thr), NCI-TCGA Cosmic COSV1007, Ensembl rs2115094180, MetaLR 0.02, MetaSVM -1.02, Variant assessed as somatic; moderate impact.
- R35C (p.Arg35Cys), rs1780508141, ClinGen CA366647929, ClinVar RCV001300431, Ensembl rs1780508141, AlphaMissense 0.53, MetaLR 0.19, Uncertain significance, Severe combined immunodeficiency due to CARD11 deficiency; BENTA disease
- R35H (p.Arg35His), Ensembl rs2115094164, REVEL 0.32, CADD 27.20
- R35L (p.Arg35Leu), Ensembl rs2115094164
- R35P (p.Arg35Pro), Ensembl rs2115094164, MetaLR 0.16, MetaSVM -0.84
- Y36C (p.Tyr36Cys), ExAC rs758661288, gnomAD rs758661288, REVEL 0.16, CADD 24.60
- A40S (p.Ala40Ser), Ensembl rs2115094123
- A40T (p.Ala40Thr), Ensembl rs2115094123
- L42F (p.Leu42Phe), Ensembl rs2115094119
- L42R (p.Leu42Arg), rs1780507887, ClinGen CA366647878, ClinVar RCV001059622, Ensembl rs1780507887, AlphaMissense 1.00, MetaLR 0.25, Uncertain significance, Severe combined immunodeficiency due to CARD11 deficiency; BENTA disease
- T43M (p.Thr43Met), rs2115094112, ClinGen CA366647874, ClinVar RCV001543387, ClinVar RCV001762722, AlphaMissense 0.80, MetaLR 0.16, Conflicting interpretations, BENTA disease; Severe combined immunodeficiency due to CARD11 deficiency; not pr
- T43R (p.Thr43Arg), rs2115094112, ClinGen CA366647873, ClinVar RCV002286326, AlphaMissense 0.80, MetaLR 0.16, Likely pathogenic, Immunodeficiency 11b with atopic dermatitis
- P44S (p.Pro44Ser), NCI-TCGA Cosmic COSV6271, MetaLR 0.17, MetaSVM -0.75, Variant assessed as somatic; moderate impact.
- Y45H (p.Tyr45His), gnomAD rs1328168126, REVEL 0.71, CADD 28.20
- L46M (p.Leu46Met), ESP rs149740754, REVEL 0.52, AlphaMissense 0.89, Uncertain significance
- L46P (p.Leu46Pro), rs2115094085, ClinGen CA366647854, ClinVar RCV002302086, Ensembl rs2115094085, AlphaMissense 1.00, MetaLR 0.48, Uncertain significance, BENTA disease; Severe combined immunodeficiency due to CARD11 deficiency
- L46V (p.Leu46Val), rs149740754, ClinGen CA366647856, ClinVar RCV001983161, ESP rs149740754, AlphaMissense 0.89, MetaLR 0.42, Uncertain significance, BENTA disease; Severe combined immunodeficiency due to CARD11 deficiency
- R47C (p.Arg47Cys), rs1780507453, ClinGen CA366647850, NCI-TCGA Cosmic COSV6271, ClinVar RCV001905798, AlphaMissense 1.00, MetaLR 0.21, Uncertain significance, Severe combined immunodeficiency due to CARD11 deficiency; BENTA disease
- R47G (p.Arg47Gly), NCI-TCGA Cosmic COSV6271, Variant assessed as somatic; moderate impact.
- R47H (p.Arg47His), rs765680532, ClinGen CA4132883, ClinVar RCV000651145, ClinVar RCV004719916, REVEL 0.62, CADD 27.30, Pathogenic/Likely pathogenic, Severe combined immunodeficiency due to CARD11 deficiency; BENTA disease; not pr
- R47P (p.Arg47Pro), ExAC rs765680532, gnomAD rs765680532, Pathogenic
- R47S (p.Arg47Ser), rs1780507453, ClinGen CA366647852, ClinVar RCV002029274, TOPMed rs1780507453, AlphaMissense 1.00, MetaLR 0.21, Uncertain significance, Severe combined immunodeficiency due to CARD11 deficiency; BENTA disease
- Q48* (p.Gln48Ter), Ensembl rs2115094060
- C49Y (p.Cys49Tyr), rs794729673, ClinGen CA203896, NCI-TCGA Cosmic COSV6271, ClinVar RCV000185616, REVEL 0.59, CADD 25.90, Pathogenic, Severe combined immunodeficiency due to CARD11 deficiency; BENTA disease
- K50N (p.Lys50Asn), rs1282104067, ClinGen CA366647826, ClinVar RCV000703759, gnomAD rs1282104067, AlphaMissense 0.95, MetaLR 0.11, Uncertain significance, Severe combined immunodeficiency due to CARD11 deficiency; BENTA disease
- V51D (p.Val51Asp), Ensembl rs2115094040, MetaLR 0.30, MetaSVM -0.35
- I52T (p.Ile52Thr), rs1780507014, ClinGen CA366647815, ClinVar RCV001046096, gnomAD rs1780507014, REVEL 0.43, CADD 26.40, Uncertain significance, Severe combined immunodeficiency due to CARD11 deficiency; BENTA disease
- D53N (p.Asp53Asn), Ensembl rs2115094030
- D53V (p.Asp53Val), Ensembl rs2115094029, MetaLR 0.18, MetaSVM -0.72
- E54K (p.Glu54Lys), Ensembl rs2115094021
- Q55* (p.Gln55Ter), NCI-TCGA Cosmic COSV1007, Ensembl rs2115094009, Variant assessed as somatic; high impact.
- D56N (p.Asp56Asn), NCI-TCGA Cosmic COSV6271, Uncertain significance, BENTA disease; Severe combined immunodeficiency due to CARD11 deficiency
- D56V (p.Asp56Val), NCI-TCGA Cosmic COSV6271, Variant assessed as somatic; moderate impact.
- D56Y (p.Asp56Tyr), Ensembl rs2115093998
- E57* (p.Glu57Ter), Ensembl rs2115093991
- E57D (p.Glu57Asp), UniProt VAR 079284, Pathogenic, in IMD11B
- E57K (p.Glu57Lys), Ensembl rs2115093991
- D58G (p.Asp58Gly), rs1780506565, ClinGen CA366647767, ClinVar RCV001057505, ClinVar RCV001543388, AlphaMissense 0.72, MetaLR 0.13, Uncertain significance, Severe combined immunodeficiency due to CARD11 deficiency; BENTA disease
- D58N (p.Asp58Asn), NCI-TCGA Cosmic COSV1007, Variant assessed as somatic; moderate impact.
- D58V (p.Asp58Val), rs1780506565, ClinGen CA366647766, ClinVar RCV001043571, Ensembl rs1780506565, AlphaMissense 0.72, MetaLR 0.13, Uncertain significance, Severe combined immunodeficiency due to CARD11 deficiency; BENTA disease
- E59G (p.Glu59Gly), Ensembl rs2115093980
- E59K (p.Glu59Lys), Ensembl rs2115093983
- V60E (p.Val60Glu), rs1583410780, ClinGen CA366647752, ClinVar RCV000797816, ClinVar RCV001543389, AlphaMissense 0.99, MetaLR 0.25, Uncertain significance, Severe combined immunodeficiency due to CARD11 deficiency; BENTA disease
- L61F (p.Leu61Phe), rs1780506319, ClinGen CA366647747, ClinVar RCV001206845, Ensembl rs1780506319, AlphaMissense 0.83, MetaLR 0.13, Uncertain significance, Severe combined immunodeficiency due to CARD11 deficiency; BENTA disease
- L61R (p.Leu61Arg), rs1780506229, ClinGen CA366647744, ClinVar RCV001047804, Ensembl rs1780506229, AlphaMissense 0.90, MetaLR 0.15, Uncertain significance, Severe combined immunodeficiency due to CARD11 deficiency; BENTA disease
- A63T (p.Ala63Thr), Ensembl rs2115093955
- A63V (p.Ala63Val), NCI-TCGA Cosmic COSV1007, Ensembl rs2115093945, MetaLR 0.05, MetaSVM -1.10, Variant assessed as somatic; moderate impact.
- P64H (p.Pro64His), Ensembl rs1583410771, Likely pathogenic
- P64R (p.Pro64Arg), rs1583410771, ClinGen CA366647726, ClinVar RCV000810731, ClinVar RCV001543390, AlphaMissense 0.25, MetaLR 0.04, Uncertain significance, BENTA disease; Severe combined immunodeficiency due to CARD11 deficiency
- M65I (p.Met65Ile), Ensembl rs2115093932
- M65V (p.Met65Val), rs1554276629, ClinGen CA366647723, ClinVar RCV000651141, Ensembl rs1554276629, AlphaMissense 0.09, MetaLR 0.04, Uncertain significance, Severe combined immunodeficiency due to CARD11 deficiency; BENTA disease
- L66M (p.Leu66Met), NCI-TCGA Cosmic COSV1007, NCI-TCGA Cosmic COSV6271, Variant assessed as somatic; moderate impact.
- P67S (p.Pro67Ser), gnomAD rs1376968211, REVEL 0.07, CADD 23.20
- S68C (p.Ser68Cys), Ensembl rs2115093914
- N71K (p.Asn71Lys), rs2115093904, ClinGen CA366647675, ClinVar RCV003804372, Ensembl rs2115093904, AlphaMissense 0.92, MetaLR 0.27, Uncertain significance, Severe combined immunodeficiency due to CARD11 deficiency; BENTA disease
- R72* (p.Arg72Ter), NCI-TCGA Cosmic COSV6271, TOPMed rs1780505575, Uncertain significance
- R72G (p.Arg72Gly), rs1780505575, ClinGen CA366647674, ClinVar RCV001226050, TOPMed rs1780505575, AlphaMissense 0.92, MetaLR 0.39, Uncertain significance, BENTA disease; Severe combined immunodeficiency due to CARD11 deficiency
- R72L (p.Arg72Leu), rs2115093887, ClinGen CA366647670, ClinVar RCV001543391, Ensembl rs2115093887, AlphaMissense 0.37, MetaLR 0.32, Likely pathogenic, Immunodeficiency 11b with atopic dermatitis
- R72Q (p.Arg72Gln), rs2115093887, ClinGen CA366647672, NCI-TCGA Cosmic COSV6271, ClinVar RCV001983408, AlphaMissense 0.37, MetaLR 0.32, Conflicting interpretations, BENTA disease; Severe combined immunodeficiency due to CARD11 deficiency; not pr
- A73S (p.Ala73Ser), ExAC rs772688973, gnomAD rs772688973, REVEL 0.10, CADD 22.70
- A73V (p.Ala73Val), TOPMed rs950377099, gnomAD rs950377099, REVEL 0.17, CADD 33.00
- G74D (p.Gly74Asp), rs2535136338, ClinGen CA366647649, NCI-TCGA Cosmic COSV1007, ClinVar RCV003043022, Uncertain significance, BENTA disease; Severe combined immunodeficiency due to CARD11 deficiency
- G74S (p.Gly74Ser), Ensembl rs2115093877
- R75L (p.Arg75Leu), Ensembl rs1064795280, Uncertain significance
- R75Q (p.Arg75Gln), rs1064795280, ClinGen CA16618451, NCI-TCGA Cosmic COSV6271, ClinVar RCV000726904, REVEL 0.20, CADD 29.70, Conflicting interpretations, Severe combined immunodeficiency due to CARD11 deficiency; BENTA disease; not pr
- R75W (p.Arg75Trp), rs2115090664, ClinGen CA366647646, ClinVar RCV001373481, ClinVar RCV002285025, AlphaMissense 0.73, MetaLR 0.16, Conflicting interpretations, Immunodeficiency 11b with atopic dermatitis; BENTA disease; Severe combined immu
- L77M (p.Leu77Met), gnomAD rs1284839637
- L77S (p.Leu77Ser), rs2535136296, ClinGen CA366647636, ClinVar RCV003056146, Uncertain significance, BENTA disease; Severe combined immunodeficiency due to CARD11 deficiency
- L77V (p.Leu77Val), gnomAD rs1284839637
- D78G (p.Asp78Gly), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- D78H (p.Asp78His), Ensembl rs2115090629
- L80P (p.Leu80Pro), rs1780440992, ClinGen CA366647613, ClinVar RCV001091306, Ensembl rs1780440992, AlphaMissense 1.00, MetaLR 0.26, Likely pathogenic, not provided
- L80V (p.Leu80Val), Ensembl rs1780441085
- T82A (p.Thr82Ala), gnomAD rs1366307164, REVEL 0.15, CADD 23.90
- K83E (p.Lys83Glu), rs2535136245, ClinGen CA366647596, ClinVar RCV002300169, Uncertain significance, Severe combined immunodeficiency due to CARD11 deficiency; BENTA disease
- G84R (p.Gly84Arg), Ensembl rs2115090588
- G84V (p.Gly84Val), NCI-TCGA TCGA novel, SIFT 0.00, Variant assessed as somatic; moderate impact.
- Q85* (p.Gln85Ter), Ensembl rs2115090580
- Q85R (p.Gln85Arg), gnomAD rs1403157349, REVEL 0.04, CADD 23.60
- R86S (p.Arg86Ser), NCI-TCGA Cosmic COSV6271, REVEL 0.31, CADD 23.80, Variant assessed as somatic; moderate impact.
- G87C (p.Gly87Cys), Ensembl rs2115090564
- G87D (p.Gly87Asp), Ensembl rs2115090558
- G87S (p.Gly87Ser), Ensembl rs2115090564
- V90F (p.Val90Phe), rs2115090528, ClinGen CA366647546, ClinVar RCV002214424, 1000Genomes rs2115090528, AlphaMissense 0.96, MetaLR 0.10, Uncertain significance, not provided
- V90I (p.Val90Ile), NCI-TCGA TCGA novel, 1000Genomes rs2115090528, REVEL 0.18, AlphaMissense 0.96, Uncertain significance
- F91L (p.Phe91Leu), rs1407244585, NCI-TCGA Cosmic COSV6271, gnomAD rs1407244585, REVEL 0.32, CADD 27.40, Variant assessed as somatic; moderate impact.
- E93K (p.Glu93Lys), NCI-TCGA Cosmic COSV6271, Variant assessed as somatic; moderate impact.
- S94I (p.Ser94Ile), Ensembl rs2115090505, SIFT 0.00
- L95Q (p.Leu95Gln), Ensembl rs2115090498, SIFT 0.00
- E96K (p.Glu96Lys), rs2535136131, ClinGen CA366647506, ClinVar RCV002287583, Uncertain significance, Immunodeficiency 11b with atopic dermatitis
- Y99* (p.Tyr99Ter), ExAC rs754050048, TOPMed rs754050048, gnomAD rs754050048
- P100S (p.Pro100Ser), Ensembl rs2115090482
- P100T (p.Pro100Thr), Ensembl rs2115090482
- L102P (p.Leu102Pro), gnomAD rs1424722453, REVEL 0.59, AlphaMissense 0.99, Uncertain significance
- L102R (p.Leu102Arg), rs1424722453, ClinGen CA366647456, ClinVar RCV001351310, gnomAD rs1424722453, AlphaMissense 0.99, MetaLR 0.21, Uncertain significance, Severe combined immunodeficiency due to CARD11 deficiency; BENTA disease
- Y103C (p.Tyr103Cys), Ensembl rs2115090463, REVEL 0.81, CADD 29.10
- V106L (p.Val106Leu), Ensembl rs2115090448
- V106M (p.Val106Met), Ensembl rs2115090448
- T107A (p.Thr107Ala), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- T107N (p.Thr107Asn), Ensembl rs2115090443, SIFT 0.00
- G108E (p.Gly108Glu), Ensembl rs2115090436
- G108R (p.Gly108Arg), NCI-TCGA Cosmic COSV6271, Ensembl rs2115090439, REVEL 0.55, CADD 26.80, Variant assessed as somatic; moderate impact.
- G108W (p.Gly108Trp), Ensembl rs2115090439
- P111H (p.Pro111His), NCI-TCGA Cosmic COSV6271, Variant assessed as somatic; moderate impact.
- P111S (p.Pro111Ser), Ensembl rs2115090422, SIFT 0.00
- R113Q (p.Arg113Gln), Ensembl rs2115090407
- R113W (p.Arg113Trp), NCI-TCGA Cosmic COSV6271, TOPMed rs1395238960, Variant assessed as somatic; moderate impact.
- R114G (p.Arg114Gly), Ensembl rs2115090397, REVEL 0.37, CADD 25.30
- R114T (p.Arg114Thr), Ensembl rs2115090393, REVEL 0.31, CADD 25.90
- T117I (p.Thr117Ile), Ensembl rs2115090387
- T117P (p.Thr117Pro), rs2535135970, ClinGen CA366647362, ClinVar RCV002286324, ClinVar RCV003774945, Uncertain significance, Severe combined immunodeficiency due to CARD11 deficiency; BENTA disease
- I118V (p.Ile118Val), gnomAD rs1780438956, REVEL 0.10, CADD 25.10
- V119L (p.Val119Leu), Ensembl rs2115090372
- V120M (p.Val120Met), Ensembl rs2115090366
- E121K (p.Glu121Lys), gnomAD rs1450598321, REVEL 0.10, CADD 24.20
- E121Q (p.Glu121Gln), NCI-TCGA Cosmic COSV1007, gnomAD rs1450598321, REVEL 0.12, CADD 28.10, Variant assessed as somatic; moderate impact.
- E122G (p.Glu122Gly), Ensembl rs2115087125
- E122Q (p.Glu122Gln), Ensembl rs2115087131
- E122V (p.Glu122Val), rs2115087125, ClinGen CA366647312, ClinVar RCV003799797, AlphaMissense 0.89, MetaLR 0.18, Uncertain significance, BENTA disease; Severe combined immunodeficiency due to CARD11 deficiency
- G123D (p.Gly123Asp), rs571517554, ClinGen CA185998, ClinVar RCV000162028, ClinVar RCV001850281, REVEL 0.22, CADD 25.20, Pathogenic, BENTA disease; Severe combined immunodeficiency due to CARD11 deficiency; not pr
- G123S (p.Gly123Ser), rs387907352, ClinGen CA143685, ClinVar RCV000041969, ClinVar RCV001057931, REVEL 0.25, CADD 25.90, Pathogenic, Severe combined immunodeficiency due to CARD11 deficiency; BENTA disease; not pr
- E125Q (p.Glu125Gln), Ensembl rs2115087090
- G126A (p.Gly126Ala), rs1423056320, ClinGen CA366647285, ClinVar RCV001996695, gnomAD rs1423056320, REVEL 0.34, AlphaMissense 0.97, Uncertain significance, Severe combined immunodeficiency due to CARD11 deficiency; BENTA disease
- G126D (p.Gly126Asp), rs1423056320, ClinGen CA366647286, NCI-TCGA Cosmic COSV6271, ClinVar RCV001619931, AlphaMissense 0.97, MetaLR 0.26, Likely pathogenic, BENTA disease; Severe combined immunodeficiency due to CARD11 deficiency; Immuno
- G126R (p.Gly126Arg), Ensembl rs2115087081
- G126S (p.Gly126Ser), NCI-TCGA Cosmic COSV1007, REVEL 0.22, CADD 26.40, Variant assessed as somatic; moderate impact.
- G126V (p.Gly126Val), gnomAD rs1423056320, SIFT 0.01, Pathogenic
- L127F (p.Leu127Phe), Ensembl rs2115087060
- L127V (p.Leu127Val), Ensembl rs2115087060
Public CARD11 analysis runs
- CARD11 analysis run — CARD11 (2,253 variants) — completed 2026-08-18